Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapy

Area of Science:

• Oncology
• Pharmacology

Background:

• Metastatic colorectal cancer (mCRC) prognosis has significantly improved since the 1990s.
• New therapeutic strategies, including oral chemotherapy and targeted biotherapy, have been developed.
• Despite advances, optimal treatment sequencing for mCRC remains undefined.

Purpose of the Study:

• To review novel anticancer drugs for colorectal carcinoma.
• To discuss new therapeutic concepts and their mechanisms of action.
• To explore strategies for better understanding and anticipating future mCRC treatments.

Main Methods:

• Literature review of recent advancements in colorectal cancer pharmacotherapy.
• Analysis of novel drug mechanisms and therapeutic concepts.
• Synthesis of current knowledge to guide future treatment strategies.

Main Results:

• Significant survival improvements observed with new drug classes.
• Emergence of oral chemotherapy and targeted biotherapy as key treatment modalities.
• Identification of challenges in optimizing drug sequencing for maximum efficacy.

Conclusions:

• Novel anticancer drugs have positively impacted mCRC outcomes.
• Further investigation into optimal drug sequencing is crucial for advancing mCRC care.
• Continued research into novel mechanisms and personalized approaches is essential for future treatment development.